Use of spiperone or spiperone derivatives as immunosuppressant agents
US5693645A · kind A · utility
18Cited by
18References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 1994 |
| Grant date | Dec 2, 1997 |
| Priority date | — |
| Expiry date | Aug 31, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/438
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating inflammatory bowel disease in a mammal that includes administering to the mammal and effective amount of spiperone or a spiperone derivative or a pharamaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.